- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Artificial Intelligence and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Mark Sentenac
News 5 results
In the News · Source: Pennsylvania Record
In the News · Source: The Legal Intelligencer
July 15, 2022
Mark Sentenac, Susan Clare and Ryan Kearney advise AbbVie and Allergan in a product liability dispute
In the News · Source: Law360, Global Competition Review, Bloomberg Law, New York Law Journal, Law.com International, Global Arbitration Review, Daily Journal, The Deal, Intellectual Property Magazine, World Trademark Review, Commercial Dispute Resolution, Global Investigations Review, Le Monde du Droit, La Lettre des Juristes d’Affaires, Daily Report, The Oath, Houston Business Journal, The Texas Lawbook and Chicago Daily Bulletin
December 3, 2021
K&S elects 32 new partners and promotes 16 counsel across 16 cities
Press Release
December 2, 2021
King & Spalding Promotes 32 New Partners and 16 Counsel Across 16 Cities
Events 4 results
Conference
September 7, 2023
16th Annual King & Spalding Medical Device Summit
Speaking Engagement
September 7, 2023
King & Spalding’s Cross-Disciplinary Life Sciences Team to Present on AI at the 16th Annual Medical Device Summit
Conference
November 1, 2022
Pharmaceutical University 2022
Webinar
November 10, 2020
13th Annual King & Spalding Medical Device Summit
Insights 3 results
Article · Source: Law360
July 6, 2023
Mitigating Risks Of Developing Drugs And Devices With AI
Article · Source: Law360
February 3, 2022
Upcoming Rulings Key To Defining PREP Act Protections
Article
January 11, 2017
Will The Learned Intermediary Doctrine Survive A New Paradigm?